日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Erbin Regulates Tissue Factors Through Ras/Raf Pathway in Coagulation Disorders in Sepsis

Erbin 通过 Ras/Raf 通路调节脓毒症凝血障碍中的组织因子

Cheng Yang #, Chuntian Lei #, Guoqing Jing, Yun Xia, Huimin Zhou, Die Wu, Jing Zuo, Hailong Gong, Xing Wang, Yingyue Dong, Delida Aidebaike, Xiaojing Wu, Xuemin Song

ERBIN limits epithelial cell plasticity via suppression of TGF-β signaling

ERBIN通过抑制TGF-β信号通路限制上皮细胞可塑性

Li, Chao; van der Zon, Gerard; Ten Dijke, Peter; Shen, Tong

Real-World Insights into Evolocumab Use in Patients with Hyperlipidemia Across Five Countries: Analysis from the ZERBINI Study

来自五个国家高脂血症患者使用依洛尤单抗的真实世界见解:ZERBINI 研究的分析

Gupta, Milan; Wani, Rajvi J; Al Faraidy, Khalid; Bergeron, Jean; Contreras, Eduardo; Peña, Angel Alberto Garcia; Mancini, G B John; Padilla, Francisco; Lopez, Abel Alberto Pavia; Philip, Kiran; Wu, Johnny; Mackinnon, Erin S

Multizonal observational study conducted by clinical practitioners on evolocumab use in subjects with hyperlipidemia in Saudi Arabia and Kuwait: Results from the ZERBINI study

由临床医生在沙特阿拉伯和科威特开展的关于依洛尤单抗在高脂血症患者中应用的多区域观察性研究:ZERBINI 研究结果

Al Faraidy, Khalid; Akbar, Mousa; Shehri, Mohamed; Aljarallah, Mohammad; Abdin Hussein, Gamal; Dashti, Raja; Al Qudaimi, Ahmad; Al Nouri, Fahad; Awan, Zuhier; Essam, Ahmed; Emara, Alaa

Targeted IL-4Rα blockade ameliorates refractory allergic eosinophilic inflammation in a patient with dysregulated TGF-β signaling due to ERBIN deficiency

靶向阻断IL-4Rα可改善因ERBIN缺陷导致TGF-β信号通路失调的患者的难治性过敏性嗜酸性粒细胞炎症。

Droghini, H Richard; Abonia, J Pablo; Collins, Margaret H; Milner, Joshua D; Lyons, Jonathan J; Freeman, Alexandra F; Mukkada, Vincent A; Risma, Kimberly A; Rothenberg, Marc E; Schwartz, Justin T

Real-World Insights Into Evolocumab Use in Patients With Hyperlipidemia: Canadian Analysis From the ZERBINI Study

来自 ZERBINI 研究的加拿大分析:依洛尤单抗在治疗高脂血症患者中的真实世界疗效

Gupta, Milan; Mancini, G B John; Wani, Rajvi J; Ahooja, Vineeta; Bergeron, Jean; Manjoo, Priya; Pandey, A Shekhar; Reiner, Maureen; Beltran, Johnny; Oliveira, Thiago; Mackinnon, Erin S

USP37 regulates DNA damage response through stabilizing and deubiquitinating BLM

USP37 通过稳定和去泛素化 BLM 来调节 DNA 损伤反应

Chenming Wu, Yiming Chang, Junliang Chen, Yang Su, Lei Li, Yuping Chen, Yunhui Li, Jinhuan Wu, Jinzhou Huang, Fei Zhao, Wenrui Wang, Hui Yin, Shunli Wang, Mingpeng Jin, Zhenkun Lou, Wei-Guo Zhu, Kuntian Luo, Jie Zhang, Jian Yuan

Erbin exerts a protective effect against inflammatory bowel disease by suppressing autophagic cell death

Erbin 通过抑制自噬细胞死亡发挥对炎症性肠病的保护作用

Tong Shen, Shi Li, Ling-Dong Cai, Jing-Lin Liu, Chu-Yi Wang, Wen-Juan Gan, Xiu-Ming Li, Jing-Ru Wang, Li-Na Sun, Min Deng, Yu-Hong Liu, Jian-Ming Li

USP13 regulates the RAP80-BRCA1 complex dependent DNA damage response

USP13 调节 RAP80-BRCA1 复合物依赖的 DNA 损伤反应

Yunhui Li, Kuntian Luo, Yujiao Yin, Chenming Wu, Min Deng, Lei Li, Yuping Chen, Somaira Nowsheen, Zhenkun Lou, Jian Yuan

Correction: ERBIN deficiency links STAT3 and TGF-β pathway defects with atopy in humans

更正:ERBIN 缺陷将 STAT3 和 TGF-β 通路缺陷与人类特应性疾病联系起来

Lyons, J J; Liu, Y; Ma, C A; Yu, X; O'Connell, M P; Lawrence, M G; Zhang, Y; Karpe, K; Zhao, M; Siegel, A M; Stone, K D; Nelson, C; Jones, N; DiMaggio, T; Darnell, D N; Mendoza-Caamal, E; Orozco, L; Hughes, J D; McElwee, J; Hohman, R J; Frischmeyer-Guerrerio, P A; Rothenberg, M E; Freeman, A F; Holland, S M; Milner, J D